Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) shares were down 1.8% on Wednesday . The stock traded as low as $0.57 and last traded at $0.57. Approximately 18,721 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 1,286,615 shares. The stock had previously closed at $0.58.
Elevai Labs Stock Performance
The company has a fifty day moving average price of $0.70.
Elevai Labs (NASDAQ:ELAB – Get Free Report) last posted its earnings results on Friday, March 29th. The company reported ($0.08) earnings per share for the quarter. The firm had revenue of $0.70 million for the quarter.
About Elevai Labs
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
Read More
- Five stocks we like better than Elevai Labs
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Comprehensive Analysis of PayPal Stock
- 5 Top Rated Dividend Stocks to Consider
- Intuitive Surgical Stock Can Trend Much Higher This Year
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
